Streetwise Reports' Article Archives — May 2019 back to current month (18)

Biopharma's LDL Cholesterol-Lowering Drug Emerges as 'Lead Stallion in Safety' (05/28/2019)

The interim study results for an in-progress trial evaluating this asset are discussed in a ROTH Capital Partners report.

more>

Biotech Identifies Antibodies for Toxic Tau in Alzheimer's Disease (05/28/2019)

The Canadian company's approach to this indication is now twofold.

more>

California-Based Biopharma Signs Licensing Deal for Acquired Asset (05/25/2019)

The transaction details and the drug platform's potential are addressed in an H.C. Wainwright & Co. report.

more>

Oncology Vaccine Developer's Lead Programs 'On Track or Better' (05/22/2019)

The biopharma's two assets are discussed and Q1/19 financial results are provided in a BTIG research report.

more>

Immuno-oncology Firm to Co-Develop Companion Diagnostic for Cervical Dysplasia (05/22/2019)

The partnership news and upcoming data readouts are reviewed in an H.C. Wainwright & Co. report.

more>

U.S. Biopharma's 'Biggest Stock Moving Event' Imminent (05/22/2019)

With study results from this company due out shortly, an analysis of the possible outcomes was provided in a ROTH Capital Partners report.

more>

Cancer Fighter Sesen Bio Leaps 13% on FDA Decision (05/21/2019)

Shares of this biotech stock were up significantly at the close of trading on Tuesday, May 21, attributed to the announcement of some good news from the FDA.

more>

Firm Takes Steps to Launch Recreational Cannabis Brand (05/17/2019)

The company continues to make preparations while it awaits receipt of a sales license.

more>

Harrow Comes Out of Allergan Lawsuit Unscathed (05/17/2019)

Sector expert Daniel Carlson offers his take on the recent jury decision, calling it "very positive."

more>

Why Did ImmunoGen Plummet 32%? (05/16/2019)

This biotechnology company, which focuses on the treatment of cancer, received some feedback from the FDA that upset investors on Wednesday.

more>

Women's Wellness Device Developer Posts In-Line Quarter, Catalysts Looming (05/15/2019)

A review of this Colorado company's first numbers of the year was provided in a Ladenburg Thalmann report.

more>

FDA Approval of Antibiotic for Bacterial Pneumonia Expected in Late Summer (05/15/2019)

An update on this biopharma's two lead drug candidate programs was provided in an H.C. Wainwright report.

more>

Biopharma Releases Preliminary Data from Alcoholic Hepatitis Study (05/10/2019)

The results compare favorably to those of the historical control group.

more>

Trial Milestone Reached; U.K.-Based Biopharma Gets $15 Million (05/08/2019)

The first patient has been treated in the second cohort of a Phase 2 study of a gene therapy targeting Parkinson's disease, explained an H.C. Wainwright & Co. report.

more>

Price Target Raised on Biopharma Ahead of Leukemia Trial Update (05/08/2019)

The expected data and their implications were addressed in a ROTH Capital Partners report.

more>

Shares of Plant-Based Meat Company Spike 53% (and It's Not Beyond Meat) (05/06/2019)

This small-cap nutrascience stock hit a new 52-week high on May 6th, extending a run that has the stock up 147% over a five-day period.

more>

'Pivotal Topline Up Next' for Biotech's Phase 3 Cardiac Clinical Trial (05/01/2019)

A study update and the next steps to advance the therapeutic were covered in a ROTH Capital Partners report.

more>

Immuno-Oncology Firm to Collaborate on Third Clinical Trial with Genentech (05/01/2019)

Descriptions of the new study and upcoming data readouts for this California-based firm were provided in an H.C. Wainwright & Co. report.

more>

More Archives

2019Aug Jul Jun May Apr Mar Feb Jan

2018Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2017Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2016Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2015Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2014Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

Notable Quotes

"DRRX earned a $10M milestone payment from Gilead."
– Ed Arce, H.C. Wainwright & Co.